Utilization of follow-up specimens from viremic blood donors to assess the value of West Nile virus immunoglobulin G avidity as an indicator of recent infection

Clinical and Diagnostic Laboratory Immunology

Volumn 12, Issue 9, 2005, Pages 1123-1126

  Prince, Harry E ^a   Lapé Nixon, Mary ^a   Busch, Michael P ^b   Tobler, Leslie H ^b   Foster, Gregory A ^c   Stramer, Susan L ^c  

^a Focus Technologies   (United States)

^b BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^c AMERICAN RED CROSS BLOOD SERVICES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BINDING AFFINITY; BLOOD DONOR; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; RISK ASSESSMENT; VIREMIA; VIRUS INFECTION; WEST NILE FLAVIVIRUS;

ANTIBODIES, VIRAL; ANTIBODY AFFINITY; BLOOD DONORS; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN G; VIREMIA; WEST NILE FEVER; WEST NILE VIRUS;

EID: 24944565882     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.12.9.1123-1126.2005     Document Type: Article

References (15)

1. Bodeus, M., S. Feyder, and P. Goubau. 1998. Avidity of IgG antibodies distinguishes primary from nonprimary cytomegalovirus infection in pregnant women. Clin. Diagn. Lab. Immunol. 9:9-16.
2. Bottinger, B., and I. P. Jensen. 1997. Maturation of rubella IgG avidity over time after acute rubella infection. Clin. Diagn. Virol. 8:105-111.
3. Busch, M. P., and S. L. Stramer. 2005. Viremia and antibody studies in WNV infected blood donors. Centers for Disease Control and Prevention West Nile virus website. [Online.] www.cdc.gov/ncidod/dvbid/westnile/conf /February_2005.htm. Accessed 8 March 2005.
4. Centers for Disease Control and Prevention. 2004. Update: West Nile virus screening of blood donations and transfusion-associated transmission-United States, 2003. Morb. Mortal. Wkly. Rep. 53:281-284.
5. Custer, B., P. A. Tomasulo, E. L. Murphy, S. Caglioti, D. Harpool, P. McEvoy, and M. P. Busch. 2004. Triggers for switching from minipool testing by nucleic acid technology to individual-donation nucleic acid testing for West Nile virus: analysis of 2003 data to inform 2004 decision making. Transfusion 44:1547-1554.
6. de Souza, V. A, S. Fernandes, E. S. Araujo, A. F. Tateno, O. M. Oliveira, R. R. Oliveira, and S. C. Pannuti. 2004. Use of an immunoglobulin G avidity test to discriminate between primary and secondary dengue virus infections. J. Clin. Microbiol. 42:1782-1784.
7. Hogrefe, W. R., R. Moore, M. Lape-Nixon, M. Wagner, and H. E. Prince. 2004. Performance of immunoglobulin G (IgG) and IgM enzyme-linked immunosorbent assays using a West Nile virus recombinant antigen (preM/E) for detection of West Nile virus- and other flavivirus-specific antibodies. J. Clin. Microbiol. 42:4641-4648.
8. Kanno, A., and Y. Kazuyama. 2002. Immunoglobulin G antibody avidity assay for serodiagnosis of hepatitis C virus infection. J. Med. Virol. 68:229-233.
9. Morrow, R. A., D. Friedrich, E. Krantz, and A. Wald. 2004. Development and use of a type-specific antibody avidity test based on herpes simplex virus type 2 glycoprotein G. Sex. Transm. Dis. 31:503-515.
10. Prince, H. E., and A. L. Leber. 2002. Validation of an in-house assay for cytomegalovirus immunoglobulin G (CMV IgG) avidity and relationship of avidity to CMV IgM levels. Clin. Diagn. Lab. Immunol. 9:824-827.
11. Prince, H. E., L. H. Tobler, M. Lape-Nixon, G. A. Foster, S. L. Stramer, and M. P. Busch. 2005. Development and persistence of West Nile virus-specific immunoglobulin M (IgM), IgA, and IgG in viremic blood donors. J. Clin. Microbiol. 43:4316-4320.
12. Puchhammer-Stockl, E., B. Schmied, A. Rieger, M. Sarcletti, M. Geit, R. Zangerle, and H. Hofmann. 2005. Low proportion of recent human immunodeficiency virus (HIV) infections among newly diagnosed cases of HIV infection as shown by the presence of HIV-specific antibodies of low avidity. J. Clin. Microbiol. 43:497-498.
13. Robertson, P., S. Beynon, R. Whybin, C. Brennan, U. Vollmer-Conna, I. Hickie, and A. Lloyd. 2003. Measurement of EBV-IgG anti-VGA avidity aids the early and reliable diagnosis of primary EBV infection. J. Med. Virol. 70:617-623.
14. Roehrig, J. T., D. Nash, B. Maldin, A. Labowitz, D. A. Martin, R. S. Lanciotti, and G. L. Campbell. 2003. Persistence of virus-reactive serum immunoglobulin M antibody in confirmed West Nile virus encephalitis cases. Emerg. Infect. Dis. 9:376-379.
15. Roque-Afonso, A. M., L. Grangeot-Keros, B. Roquebert, D. Desbois, J. D. Poveda, V. Mackiewicz, and E. Dussaix. 2004. Diagnostic relevance of immunoglobulin G avidity for hepatitis A virus. J. Clin. Microbiol. 42:5121-5124.